Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Clin Cancer Res. 2011 Mar 29;17(10):3388–3397. doi: 10.1158/1078-0432.CCR-10-2876

Table 3.

Treatment response by schema and diagnosis

Response Non-Hodgkin’s Lymphoma (n=9) Multiple Myeloma* (n=7) All (n=16)
Complete remission (CR) 1 1 2
Partial remission (PR) 2 3,§ 5
CR + PR (%) 3 (33%) 4 (57%) 7 (44%)
*

Includes 1 patient with extramedullary plasmacytoma.

Includes 1 patient with mantle cell lymphoma.

Includes 1 patient with prior auto stem cell transplant.

§

Includes 1 patient previously treated with bortezomib.